Bortezomib-induced skin lesion.
Ozcan
Mehmet Ali
MA
Institute of Oncology, Division of Hematology, Faculty of Medicine, Dokuz Eylul University, Izmir, Turkey. mehmet.ozcan@deu.edu.tr
Alacacioglu
Inci
I
Piskin
Ozden
O
Lebe
Banu
B
Turgut
Nurhilal
N
Ceneli
Selda
S
Demirkan
Fatih
F
Ozsan
Guner Hayri
GH
Undar
Bulent
B
D000369:Aged, 80 and over; D001897:Boronic Acids / Q000009:adverse effects*; D000069286:Bortezomib; D003875:Drug Eruptions / Q000209:etiology* / Q000473:pathology; D005260:Female; D006801:Humans; D009101:Multiple Myeloma / Q000188:drug therapy; D011719:Pyrazines / Q000009:adverse effects*
D001897:Boronic Acids; D011719:Pyrazines; D000069286:Bortezomib